Mucinous adenocarcinoma is an unfavorable subtype of colon cancer with unique distinct clinical histopathological characteristics due to different microsatellite instability, mucin is a target for molecular therapy with specific genetic mutation. This evidence concerns the gene MUC5AC and mucinous adenocarcinoma.